Trans-Pacific Partnership Agreement: Harmful provisions for access to medicines The Trans-Pacific Partnership (TPP) is a proposed free trade agreement between 12 countries in the Asia-Pacific including the United States.

First Page		Document Content
Date: 2014-06-18 15:48:38 Law Pharmacology Test data exclusivity Evergreening Generic drug Pharmaceutical industry Chemical patent Patent Term of patent Patent law Pharmaceuticals policy Pharmaceutical sciences		Trans-Pacific Partnership Agreement: Harmful provisions for access to medicines The Trans-Pacific Partnership (TPP) is a proposed free trade agreement between 12 countries in the Asia-Pacific including the United States. Add to Reading List Source URL: www.citizen.org Download Document from Source Website File Size: 311,85 KB Share Document on Facebook

	B.12 AF user guide consolidated vet version EMA DocID: 1pz2w - View Document
	CMDh_132_2009_Rev38_2015 12_clean DocID: 1pjXq - View Document
	280 The Protection of Proprietary Data in Novel Foods EFFL DocID: 1p89m - View Document
	CMDh QUESTIONS & ANSWERS GENERIC APPLICATIONS Doc. Ref.: CMDh, Rev.1 AprilSUBMISSION OF A DESCRIPTION OF PHARMACOVIGILANCE SYSTEM AND EU RISK DocID: 1oJjO - View Document
	Ecuador Takes One Step Forward for Health (Issues New Compulsory Licenses) and One Step Back (Signs Harmful Trade Agreement with the EU) In July, Ecuador issued four compulsory licenses for medicines targeting cancer and DocID: 1964U - View Document